See more : byNordic Acquisition Corporation (BYNOW) Income Statement Analysis – Financial Results
Complete financial analysis of Radiopharm Theranostics Limited (RAD.AX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Radiopharm Theranostics Limited, a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- Seafarer Exploration Corp. (SFRX) Income Statement Analysis – Financial Results
- YANGAROO Inc. (YOOIF) Income Statement Analysis – Financial Results
- Aspen Pharmacare Holdings Limited (APN.JO) Income Statement Analysis – Financial Results
- Jain Marmo Industries Ltd. (JAINMARMO.BO) Income Statement Analysis – Financial Results
- Spring Ventures Ltd (SPRG.TA) Income Statement Analysis – Financial Results
Radiopharm Theranostics Limited (RAD.AX)
About Radiopharm Theranostics Limited
Radiopharm Theranostics Limited develops radiopharmaceutical products for diagnostic and therapeutic uses. The company was incorporated in 2021 and is based in Carlton, Australia.
| Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Revenue | 299.23K | 292.36K | 8.83K | 0.00 |
| Cost of Revenue | 21.61M | 3.30M | 2.98M | 0.00 |
| Gross Profit | -21.31M | -3.00M | -2.97M | 0.00 |
| Gross Profit Ratio | -7,121.04% | -1,027.56% | -33,661.57% | 0.00% |
| Research & Development | 17.56M | 22.03M | 4.12M | 0.00 |
| General & Administrative | 13.04M | 13.02M | 12.44M | 300.64K |
| Selling & Marketing | 2.18M | 2.24M | 0.00 | 184.12K |
| SG&A | 15.22M | 15.26M | 12.44M | 484.75K |
| Other Expenses | -32.48M | 2.98M | -1.03M | 0.00 |
| Operating Expenses | 299.23K | 37.29M | 20.95M | 484.75K |
| Cost & Expenses | 38.77M | 40.58M | 20.95M | 484.75K |
| Interest Income | 50.48K | 145.04K | 8.83K | 0.00 |
| Interest Expense | 642.89K | 86.09K | 9.35M | 0.00 |
| Depreciation & Amortization | 3.13M | 3.30M | 2.98M | 1.16M |
| EBITDA | -45.38M | -31.19M | -18.04M | -484.75K |
| EBITDA Ratio | -15,164.41% | -12,654.25% | -237,174.08% | 0.00% |
| Operating Income | -36.62M | -40.29M | -23.93M | -484.75K |
| Operating Income Ratio | -12,238.44% | -13,781.81% | -270,935.65% | 0.00% |
| Total Other Income/Expenses | -11.23M | -6.00M | -10.38M | 679.27K |
| Income Before Tax | -47.85M | -40.49M | -30.29M | -485.19K |
| Income Before Tax Ratio | -15,992.07% | -13,849.64% | -343,048.15% | 0.00% |
| Income Tax Expense | 96.36K | -5.88M | 44.40K | -1.16M |
| Net Income | -47.95M | -34.61M | -30.34M | -485.19K |
| Net Income Ratio | -16,024.28% | -11,838.59% | -343,550.89% | 0.00% |
| EPS | -0.12 | -0.11 | -0.11 | 0.00 |
| EPS Diluted | -0.12 | -0.11 | -0.11 | 0.00 |
| Weighted Avg Shares Out | 386.46M | 323.82M | 279.77M | 277.47M |
| Weighted Avg Shares Out (Dil) | 386.46M | 323.82M | 279.77M | 277.47M |
No news found for: RAD.AX
Source: https://incomestatements.info
Category: Stock Reports